LLY vs BDX
By Alex · Tickerpine
Eli Lilly and Company vs Becton, Dickinson and Company, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | BDX |
|---|---|---|
| Price | $1,184.78 | $183.83 |
| Market cap | $1.06T | $50.07B |
| P/E ratio | 39.7 | 31.9 |
| ROE | 102.29% | 6.61% |
| Profit margin | 33.53% | 4.19% |
| Revenue growth | 47.70% | 5.40% |
| Dividend yield | 0.58% | 2.28% |
| Beta | 0.50 | 0.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs BDX in plain English
- LLY is the bigger company — about 21.1× the market cap of BDX.
- BDX is cheaper on earnings (P/E 31.9 vs 39.7).
- LLY earns a higher return on equity (102% vs 7%).
- LLY is growing revenue faster (48% vs 5%).
- BDX has the higher dividend yield (2.28% vs 0.58%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
BDX return calculator
See what $1,000 in Becton, Dickinson and Company would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.